Clinical Trial Update: An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczema [Phase 2]

View source ↗

Summary

Phase 2 investigator-initiated trial evaluating apremilast for efficacy in Nummular Eczema (dermatitis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Dermatitis Eczema
• Nummular Dermatitis
• Nummular Eczema

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Technical University of Munich | Conditions: Nummular Eczema, Eczema | Phase 2 | Status: COMPLETED